Skip to main content
NASDAQ:AVCO

Avalon GloboCare News Headlines

$1.08
+0.02 (+1.89 %)
(As of 05/18/2021 12:00 AM ET)
Add
Compare
Today's Range
$1.02
$1.15
50-Day Range
$0.88
$1.13
52-Week Range
$0.87
$2.16
Volume411,780 shs
Average Volume443,990 shs
Market Capitalization$91.16 million
P/E RatioN/A
Dividend YieldN/A
Beta0.57

Headlines

Avalon GloboCare (NASDAQ AVCO) News Headlines Today

SourceHeadline
Avalon GloboCare (NASDAQ:AVCO) Stock Price Down 7.7%Avalon GloboCare (NASDAQ:AVCO) Stock Price Down 7.7%
americanbankingnews.com - May 7 at 12:10 AM
Avalon GloboCare is seeking to tap the power of cells to fight cancer and coronavirusAvalon GloboCare is seeking to tap the power of cells to fight cancer and coronavirus
proactiveinvestors.com - April 20 at 11:19 AM
Is Avalon GloboCare (NASDAQ:AVCO) A Risky Investment?Is Avalon GloboCare (NASDAQ:AVCO) A Risky Investment?
nasdaq.com - April 8 at 12:52 PM
Avalon GloboCare to partner with University of Pittsburgh Medical Center Hillman Cancer Center to develop therapies using FLASH-CAR techAvalon GloboCare to partner with University of Pittsburgh Medical Center Hillman Cancer Center to develop therapies using FLASH-CAR tech
proactiveinvestors.com - March 29 at 3:27 PM
Avalon GloboCare Announces Collaboration with the University of Pittsburgh Medical Center Hillman Cancer Center to Advance Clinical Development of Cellular Immunotherapies Using the FLASH-CAR™ PlatformAvalon GloboCare Announces Collaboration with the University of Pittsburgh Medical Center Hillman Cancer Center to Advance Clinical Development of Cellular Immunotherapies Using the FLASH-CAR™ Platform
finance.yahoo.com - March 29 at 3:27 PM
Avalon GloboCare expands its MIT co-development research program to fight cancer spreadAvalon GloboCare expands its MIT co-development research program to fight cancer spread
proactiveinvestors.com - March 22 at 1:21 PM
Avalon GloboCare Expands Co-Development Program with MIT to Combat Cancer MetastasisAvalon GloboCare Expands Co-Development Program with MIT to Combat Cancer Metastasis
finance.yahoo.com - March 22 at 1:21 PM
Avalon GloboCare seeking to tap the power of cells to fight cancer and coronavirusAvalon GloboCare seeking to tap the power of cells to fight cancer and coronavirus
proactiveinvestors.com - March 15 at 2:26 PM
What Kind Of Shareholders Hold The Majority In Avalon GloboCare Corp.s (NASDAQ:AVCO) Shares?What Kind Of Shareholders Hold The Majority In Avalon GloboCare Corp.'s (NASDAQ:AVCO) Shares?
finance.yahoo.com - January 23 at 12:21 PM
Avalon GloboCare issues update on its partnership with the Institute for Synthetic Bioarchitectures in Vienna, AustriaAvalon GloboCare issues update on its partnership with the Institute for Synthetic Bioarchitectures in Vienna, Austria
proactiveinvestors.com - December 30 at 1:40 PM
Avalon GloboCare and University of Natural Resources and Life Sciences (BOKU) Expand Partnership and Accelerate Development of S-Layer Based Vaccines and Cellular TherapeuticsAvalon GloboCare and University of Natural Resources and Life Sciences (BOKU) Expand Partnership and Accelerate Development of S-Layer Based Vaccines and Cellular Therapeutics
finance.yahoo.com - December 30 at 1:40 PM
Avalon Globocare featured in article running in Nature’s Biopharma Dealmaker December editionAvalon Globocare featured in article running in Nature’s Biopharma Dealmaker December edition
proactiveinvestors.com - December 3 at 1:43 AM
Avalon GloboCares(NASDAQ:AVCO) Share Price Is Down 59% Over The Past Three Years.Avalon GloboCare's(NASDAQ:AVCO) Share Price Is Down 59% Over The Past Three Years.
finance.yahoo.com - November 17 at 7:25 AM
Avalon GloboCare Corp. Common Stock (AVCO)Avalon GloboCare Corp. Common Stock (AVCO)
nasdaq.com - October 30 at 3:22 PM
Avalon GloboCare and Adial Pharmaceuticals Announce Strategic Collaboration for Global Distribution of COVID-19 Point-of-CareAvalon GloboCare and Adial Pharmaceuticals Announce Strategic Collaboration for Global Distribution of COVID-19 Point-of-Care
bloomberg.com - October 24 at 6:18 PM
The COVID-19 Pandemic Continues To Fuel Corporate IngenuityThe COVID-19 Pandemic Continues To Fuel Corporate Ingenuity
baystreet.ca - October 22 at 3:44 PM
Avalon GloboCare and Adial Pharma rallies on strategic collaborationAvalon GloboCare and Adial Pharma rallies on strategic collaboration
seekingalpha.com - October 22 at 10:42 AM
Avalon GloboCare and Adial Pharmaceuticals Announce Strategic Collaboration for Global Distribution of COVID-19 Point-of-Care Antibody Rapid Test DevicesAvalon GloboCare and Adial Pharmaceuticals Announce Strategic Collaboration for Global Distribution of COVID-19 Point-of-Care Antibody Rapid Test Devices
finance.yahoo.com - October 22 at 10:42 AM
Avalon GloboCare Provides Clinical Updates on Its...Avalon GloboCare Provides Clinical Updates on Its...
benzinga.com - October 3 at 1:20 PM
Avalon expands AVA-001 trial to non-Hodgkin lymphoma patients; plans acute respiratory distress syndrome trial for later this yearAvalon expands AVA-001 trial to non-Hodgkin lymphoma patients; plans acute respiratory distress syndrome trial for later this year
proactiveinvestors.com - October 1 at 1:39 PM
Avalon GloboCare to add NHL patients to lead CAR T studyAvalon GloboCare to add NHL patients to lead CAR T study
seekingalpha.com - October 1 at 1:39 PM
Avalon GloboCare to include R/R NHL patients for lead CAR T-cell therapy trialAvalon GloboCare to include R/R NHL patients for lead CAR T-cell therapy trial
seekingalpha.com - October 1 at 1:39 PM
Avalon GloboCare launches its new MSC platform as a potential therapy for coronavirus (COVID-19)Avalon GloboCare launches its new MSC platform as a potential therapy for coronavirus (COVID-19)
proactiveinvestors.com - September 6 at 11:41 PM
Avalon GloboCare Announces Mesenchymal Stromal Cell Therapeutic Platform for COVID-19 and Acute Graft Versus Host Disease (aGVHD)Avalon GloboCare Announces Mesenchymal Stromal Cell Therapeutic Platform for COVID-19 and Acute Graft Versus Host Disease (aGVHD)
finance.yahoo.com - September 3 at 1:50 PM
Avalon GloboCare CEO to Participate in Virtual Panel: “New Approaches to COVID-19: Hidden Breakthroughs,” on Thursday, September 10thAvalon GloboCare CEO to Participate in Virtual Panel: “New Approaches to COVID-19: Hidden Breakthroughs,” on Thursday, September 10th
finance.yahoo.com - September 3 at 1:50 PM
Have Insiders Been Buying Avalon GloboCare Corp. (NASDAQ:AVCO) Shares?Have Insiders Been Buying Avalon GloboCare Corp. (NASDAQ:AVCO) Shares?
finance.yahoo.com - September 1 at 3:21 PM
Avalon GloboCare preparing to begin its first in-human clinical trial to test coronavirus vaccineAvalon GloboCare preparing to begin its first in-human clinical trial to test coronavirus vaccine
proactiveinvestors.com - August 25 at 5:39 PM
Why Avalon Globocare's Stock Is Trading Higher TodayWhy Avalon Globocare's Stock Is Trading Higher Today
finance.yahoo.com - August 19 at 6:54 PM
Avalon GloboCare wins distribution rights to market Cellex’s COVID-19 antibody-based rapid test kitAvalon GloboCare wins distribution rights to market Cellex’s COVID-19 antibody-based rapid test kit
proactiveinvestors.com - August 19 at 1:54 PM
Avalon GloboCare up 16% on COVID-19 test dealAvalon GloboCare up 16% on COVID-19 test deal
seekingalpha.com - August 19 at 1:54 PM
Avalon GloboCare Announces Commercialization and Distribution Agreement with Cellex for COVID-19 Antibody Rapid Test KitAvalon GloboCare Announces Commercialization and Distribution Agreement with Cellex for COVID-19 Antibody Rapid Test Kit
finance.yahoo.com - August 19 at 1:54 PM
Why Avalon Globocares Stock Is Trading Higher TodayWhy Avalon Globocare's Stock Is Trading Higher Today
feeds.benzinga.com - August 19 at 11:17 AM
Avalon GloboCare Expands AVA-Trap™ Program to Treat COVID-19 and CAR-T Related Cytokine StormsAvalon GloboCare Expands AVA-Trap™ Program to Treat COVID-19 and CAR-T Related Cytokine Storms
finance.yahoo.com - August 12 at 1:33 PM
Avalon GloboCare updates investors on cell therapy and coronavirus programs as it launches COVID-19 taskforceAvalon GloboCare updates investors on cell therapy and coronavirus programs as it launches COVID-19 taskforce
www.proactiveinvestors.com - July 13 at 2:27 PM
Avalon GloboCare Provides Updates on its Lead Scientific and Clinical Programs in CAR T-Cell Therapy and COVID-19Avalon GloboCare Provides Updates on its Lead Scientific and Clinical Programs in CAR T-Cell Therapy and COVID-19
finance.yahoo.com - July 13 at 9:27 AM
Heres What Avalon GloboCare Corp.s (NASDAQ:AVCO) Shareholder Ownership Structure Looks LikeHere's What Avalon GloboCare Corp.'s (NASDAQ:AVCO) Shareholder Ownership Structure Looks Like
finance.yahoo.com - July 3 at 5:56 PM
Here's What Avalon GloboCare Corp.'s (NASDAQ:AVCO) Shareholder Ownership Structure Looks LikeHere's What Avalon GloboCare Corp.'s (NASDAQ:AVCO) Shareholder Ownership Structure Looks Like
finance.yahoo.com - July 3 at 5:56 PM
Avalon GloboCare successfully completes Phase I first-in-human clinical study of its leading Chimeric Antigen Receptor (CAR) T-cell therapy candidateAvalon GloboCare successfully completes Phase I first-in-human clinical study of its leading Chimeric Antigen Receptor (CAR) T-cell therapy candidate
www.proactiveinvestors.com - June 29 at 2:39 PM
Avalon GloboCares CAR-T therapy completes early-stage study in B-cell malignanciesAvalon GloboCare's CAR-T therapy completes early-stage study in B-cell malignancies
seekingalpha.com - June 29 at 2:39 PM
Avalon GloboCare Announces Successful Completion of Phase I Clinical Study of CAR T-Cell Therapy Candidate AVA-001Avalon GloboCare Announces Successful Completion of Phase I Clinical Study of CAR T-Cell Therapy Candidate AVA-001
finance.yahoo.com - June 29 at 9:38 AM
Avalon GloboCare Achieves Milestones in Advancing Novel Intranasal and Oral COVID-19 Vaccine CandidateAvalon GloboCare Achieves Milestones in Advancing Novel Intranasal and Oral COVID-19 Vaccine Candidate
finance.yahoo.com - June 25 at 9:49 AM
Avalon GloboCare welcomes S-layer expert Professor Sleytr to its scientific and clinical advisory boardAvalon GloboCare welcomes 'S-layer' expert Professor Sleytr to its scientific and clinical advisory board
www.proactiveinvestors.com - June 16 at 1:01 PM
Eminent Member of the Austrian Academy of Sciences, Professor Uwe B. Sleytr, Joins Avalon GloboCares Scientific and Clinical Advisory BoardEminent Member of the Austrian Academy of Sciences, Professor Uwe B. Sleytr, Joins Avalon GloboCare's Scientific and Clinical Advisory Board
finance.yahoo.com - June 16 at 1:01 PM
Avalon GloboCare strikes three-way material transfer agreement with Weill Cornell Medicine and Arbele LimitedAvalon GloboCare strikes three-way material transfer agreement with Weill Cornell Medicine and Arbele Limited
www.proactiveinvestors.com - June 11 at 2:56 PM
BRIEF-Avalon GloboCare Announces Agreement For Development Of Next Generation Cellular Immunotherapy Flash-Car TechnologyBRIEF-Avalon GloboCare Announces Agreement For Development Of Next Generation Cellular Immunotherapy Flash-Car Technology
www.reuters.com - June 11 at 9:55 AM
Avalon GloboCare Announces Three-Way Material Transfer Agreement with Weill Cornell Medicine and Arbele Limited for Development of Next Generation Cellular Immunotherapy FLASH-CAR™ TechnologyAvalon GloboCare Announces Three-Way Material Transfer Agreement with Weill Cornell Medicine and Arbele Limited for Development of Next Generation Cellular Immunotherapy FLASH-CAR™ Technology
finance.yahoo.com - June 11 at 9:55 AM
BRIEF-Avalon Globocare Announces Diagnostic Platform For Point-Of-Care Rapid Detection Of Covid-19 And Its Clinically Relevant Mutation StrainsBRIEF-Avalon Globocare Announces Diagnostic Platform For Point-Of-Care Rapid Detection Of Covid-19 And Its Clinically Relevant Mutation Strains
www.reuters.com - June 8 at 1:30 PM
Avalon GloboCare forms strategic partnership to co-develop rapid detection SARS-CoV-2 antibody testsAvalon GloboCare forms strategic partnership to co-develop rapid detection SARS-CoV-2 antibody tests
www.proactiveinvestors.com - June 8 at 1:30 PM
Avalon Globocare to develop diagnostic platform for point-of-care rapid detection of COVID-19Avalon Globocare to develop diagnostic platform for point-of-care rapid detection of COVID-19
seekingalpha.com - June 8 at 1:30 PM
Avalon Globocare inks deal for COVID-19 testsAvalon Globocare inks deal for COVID-19 tests
seekingalpha.com - June 8 at 1:30 PM
This page was last updated on 5/18/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.